ABI
VictoryShares Pioneer Asset-Based Income ETF
Latest price
As of Nov 5, 2026, 1:02 PM EST · Market data by Massive
Market cap
—
Volume
29.3K
Previous close
$24.60
Day range
$24.60 – $24.63
Listed
Jun 25, 2025
Coverage
2 articles
Price performance
Recent trading
Newsroom
Latest ABI coverage
Amarillo Biosciences to Initiate Low-Dose Interferon Clinical Trials to Treat COVID-19, Appoints Interferon Specialist Dr. Manfred Beilharz to Scientific Advisory Board
[ad_1] Amarillo, TX – (NewMediaWire) – September 10, 2020 – Amarillo Biosciences, Inc. (“ABI” or the “Company”), (AMAR), the world leader in low-dose non-injectable interferon research, is pleased to announce the appointment of Dr. Manfred Beilharz, Associate Professor at The University of Western Australia and renown pioneer in interferon
Amarillo Biosciences to Reaffirm Low-Dose Interferon Research Leadership Position and Global Commitment to Support Related Therapeutics
[ad_1] Amarillo, Texas – (NewMediaWire) – August 13, 2020 – Amarillo Biosciences, Inc. (“ABI” or the “Company”), (AMAR), a diversified healthcare company, today announced that it is taking steps to reaffirm its position as the world leader in low-dose non-injectable interferon research. ABI will strengthen its commitmen